EyePoint Pharmaceuticals, Inc. — Form D

EyePoint Pharmaceuticals, Inc. of WATERTOWN, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-04-12. The offering totals $600K, of which $450K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Scott JonesExecutive OfficerAustin, TX
Michael RogersDirectorEDEN PRAIRIE, MN
James BarryDirectorAMERICAN CANYON, CA
Kristine PetersonDirectorAbingdon, Oxfordshire, X0
Nancy LurkerDirectorWATERTOWN, MA
Nancy LurkerExecutive OfficerWATERTOWN, MA
Dario Paggiarino, M.D.Executive OfficerWATERTOWN, MA
Goran AndoDirectorWATERTOWN, MA
George O ElstonExecutive OfficerWatertown, MA
Wendy O DiCiccoDirectorWatertown, MA
Ronald W EastmanDirectorWatertown, MA
Douglas W GodshallDirectorWatertown, MA
David R Guyer, M.D.DirectorWatertown, MA
John R Landis, Ph.D., M.S.DirectorWatertown, MA
Ye R LiuDirectorWatertown, MA
David MazzoDirectorGermantown, MD
Douglas GodshallDirectorSanta Clara, CA
Dario S PaggiarinoExecutive OfficerWATERTOWN, MA
Leonard S RossExecutive OfficerWATERTOWN, MA
Jay DukerDirectorWATERTOWN, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2021-01-06D$15.7M$15.7M
2018-04-12D$35.0M$9.5M

More